“takeda-ventures” Archives

Entry Author Date Location
Palleon Lands $48M to Develop New Type of Checkpoint Cancer Drug 10/04/17 Boston
Avidity Biosciences Receives $16,000,000 Series B Funding 01/06/17 San Diego
Cerevance Lands $36,000,000 Series A Financing 12/06/16 Boston
Bioniz Therapeutics Secures $13,000,000 Series A Round 08/03/16 San Diego
Mersana Therapeutics Receives $33,000,000 Series C Financing 06/16/16 Boston
Aquinnah Pharmaceuticals Obtains $5,000,000 New Financing 12/22/15 Boston
Prosetta Biosciences Receives $31,000,000 Series D Funding Round 12/04/15 San Francisco
West Coast Biotech Roundup: Adaptive, Synthorx, USC v. UCSD, 23andMe 08/20/15 San Diego
Seattle Genetics Secures $9,000,000 New Financing Round 01/21/14 Seattle
Redwood Bioscience Secures New Round 04/23/13 San Francisco
Naurex Lands $38,000,000 Series B Financing 12/17/12 Detroit Ann Arbor
ArmaGen Technologies Obtains $17,000,000 Series A Funding Round 12/03/12 San Diego
Juventas Therapeutics Receives $22,200,000 Series B Financing 07/17/12 Detroit Ann Arbor
Fate Therapeutics Trims Chemistry Staff, Bets on Biotech Drugs 07/07/11 National
Naurex Secures $18,000,000 Series A Funding Round 05/11/11 Detroit Ann Arbor
Fate Therapeutics Lands New Funding 05/10/11 San Diego
Page 1 of 1